FDA Orange Book · active-ingredient family
Cupric chloride
Cupric chloride is approved as 1 brand and 4 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:CUPRIC CHLORIDE IN PLASTIC CONTAINER · NDA 018960
1
Brand (NDA)
4
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CUPRIC CHLORIDE IN PLASTIC CONTAINERRLD | HOSPIRA | NDA 018960 | AP | Jun 26, 1986 |
Generic (ANDA) products (4)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CUPRIC CHLORIDE | AMNEAL | ANDA 217287 | — | Jan 26, 2026 | |
| CUPRIC CHLORIDE | SOMERSET | ANDA 216113 | AP | Apr 30, 2024 | |
| CUPRIC CHLORIDE | STIRA | ANDA 217626 | AP | Apr 30, 2024 | |
| CUPRIC CHLORIDE | EXELA PHARMA | ANDA 212071 | AP | Oct 31, 2022 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Cupric chloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
